USD 97.93 Billion
Immunology Market Size, Share, Growth Analysis, By Drug Class(Monoclonal Antibody, Immunosuppressants,, Fusion Proteins), By Disease Indication(Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35H2245 |
Region:
Global |
Published Date: October, 2024
Pages:
157
|Tables:
68
|Figures:
75
Immunology Market Insights
Global Immunology Market size was valued at USD 95.8 billion in 2022 and is poised to grow from USD 107.49 billion in 2023 to USD 269.96 billion by 2031, growing at a CAGR of 12.20% during the forecast period (2024-2031).
The immunology market growth is primarily driven by increasing popularity of immunology therapy due to disorders like sclerosis, rheumatoid arthritis, and inflammatory bowel. Immunology consists of a wide range of medications, treatments, diagnostics, and research instruments. These solutions can identify, manage, or prevent immune-mediated diseases, like allergies, cancer, immunotherapy, autoimmune diseases, and infectious problems. Biotechnological techniques are used for developing medications and treatments and they generally target immune system components for changing their activities. Some of the common examples of immunology are vaccines, immunomodulators, and monoclonal antibodies.
For immunology diagnostics tests and assays are utilized for evaluating the performance of immune system, finding antibodies, antigens, and other immunological markers that can indicate diseases. Some of the common examples of tests and assays are ELISA assays, flow cytometry, and PCR-based diagnostics. Furthermore, immunotherapy has also become a common treatment option for cancer, particularly for melanoma, lung cancer, and several hematological malignancies. It is anticipated that research related to immunotherapy will continue to increase in the application of oncology to identify new targets and therapeutic approaches.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Fastest Growth
Growth Rate
8.5% CAGR
Global Immunology Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Immunology Market Segmental Analysis
Global Immunology Market is segmented by Drug Class, Disease Indication, Distribution Channel, and region. Based on Drug Class, the market is segmented into Monoclonal Antibody, Immunosuppressants, Fusion Proteins, Others. Based on Disease Indication, the market is segmented into Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Analysis by Drug Class
Based on drug class, monoclonal antibody segment is dominating the market with the largest immunology market share. The monoclonal antibody is witnessing huge demand owing to its accuracy and effectiveness against specified antigens. Monoclonal antibodies play an essential role in the treatment of autoimmune diseases, cancers, and chronic inflammatory disorders. However, with the progress on biotechnology, the latest monoclonal antibody therapies have higher specificity, minimize the side effects and improve the patient outcomes. Market players are also investing heavily in the research and development of next generation antibodies like bispecific antibodies, conjugated monoclonal antibodies. In addition to the above, favorable reimbursement policies and government initiatives in support of the development of biologics are expected to accelerate the growth of this market. Additionally, the increasing instances of autoimmune disorders such as rheumatoid arthritis and Crohn's disease is another factor that is increasing its demand.
The immunosuppressants segment is witnessing the fastest growth in the immunology market. Immunosuppressants are essential for the treatment of autoimmune disease and for the prevention of organ transplant rejection. High demand for the segment due to the growing prevalence associated to multiple sclerosis, lupus and psoriasis among others. Improved drug delivery methods such as modified release and targeted therapies are improving compliance and response to treatment. Pharmaceutical industry is now targeting on drug discovery with high safety profile and personalized medicine methods. Also, continuous increase in use of combination therapies for optimizing treatment outcomes and minimizing dose-dependent toxicity is further contributing to the growth of the segment.
Analysis by Distribution Channel
Based on distribution channel, the hospital pharmacies segment is dominating the immunology market. Hospital pharmacies continue to be an important channel for distribution of immunology drugs, as they provide full access to life-saving therapies, especially among the hospital setting for acute autoimmune disease and transplantation. The centrally located nature of hospitals helps in administering these drugs within a particular prescribed time as the segment involves administration of specialized drugs such as monoclonal antibodies and high-potency immune suppressants. A growing number of hospital-based infusion centers, along with partnerships with pharmaceutical companies, make it more accessible and affordable. In addition, the digitization and infrastructures of the hospitals aid in streamlining the drug available for inventory and the patient records. But high operational cost and scrutiny of the regulatory bodies have become obstacles. The segment is expected to grow owing to the increasing hospital admission for autoimmune disorders and organ transplants and programs to expand access to healthcare in developing countries.
As per immunology market analysis, the online pharmacies segment is expected to witness the fastest growth during the forecast period. Online pharmacies are progressively emerging as an efficient and cheaper source of distribution channel for immunology drugs. Factors such as increasing penetration of internet, digital health platforms, and rising demand for home delivery services by consumers is driving the growth for this segment. They provide a variety of immunology medications such as monoclonal antibodies and immunosuppressants at competitive rates. Improved features such as e-prescriptions, subscription refills, and patient assistance programs foster customer loyalty. The growth of the market is also boosted by regulatory changes favoring e-pharmacy operations and secure transactions. However, counterfeit drugs and differing regional regulations pose challenges that will need to be addressed. But the growing telemedicine and adoption of artificial intelligence to personalize medicine management will create lucrative opportunities for online pharmacies in the immunology market.
To get detailed analysis on other segments, Request For Free Sample Report
Immunology Market Regional Insights
North America is dominating with the largest immunology market share. North America commands the revenue share in the immunology market, attributed to the well-established healthcare system and suitable level of R&D investment. The U.S. is the largest market share holder, with a significant presence of autoimmune diseases and many leading pharmaceutical companies. Government initiatives are increasing as they are providing funds to increase research related to immunology, leading to the growth of the market. Canada is also contributing to the market growth by showing an increased focus on biologics and biosimilars. This dynamic has instigated proactive initiatives by key players within the region in the form of strategic partnerships and clinical trials, aimed at commercializing innovative therapies. Moreover, increasing awareness among patients as well as availability of advanced diagnostics has amplified early diagnostics and treatment thereby, supporting the continued growth of the North America immunology market.
The Asia-Pacific market is witnessing the fastest growth in the immunology market. The Asia Pacific immunology market is growing at a rapid phase which is primarily attributed to the rising healthcare awareness along with the increasing prevalence of chronic diseases. Countries such as China and India are leading the way, pouring investments into both biotechnology and pharmaceutical manufacturing. The government in this region is also implementing policies for supporting local drug development programs and wider accessibility to healthcare. Moreover, the region's vast pool of patients and improving healthcare infrastructure have helped attract global players interested in addressing unmet medical needs. This cluster of growth opportunities in the region aligns with the increased adoption of new immunology therapies and biosimilars.
Global Immunology Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Immunology Market Dynamics
Immunology Market Drivers
Growing Prevalence of Autoimmune Diseases
-
The growing incidence of autoimmune diseases such as rheumatoid arthritis, lupus, and multiple sclerosis are a major factor propelling growth of the immunology market. The prevalence of these chronic conditions is increasing as they arise from genetic or environmental factors. Increased public awareness of autoimmune diseases and enhanced focus on early testing to prevent disease progression has increased the uptake of immunology related treatment options. Such a rise is additionally supported by government and private funding initiatives to increase access to luxury treatments.
Advancement in Biologics and Biosimilars
-
Biologics and biosimilars are changing the face of immunology. Biologics provide enhanced efficacy because they target specific pathways of disease, especially for complex immune-mediated conditions. At the same time, biosimilars are often providing high quality, cost-effective alternatives, and enabling accessibility in cost-sensitive markets. These advancements are backed by substantial research and development efforts from major market players. Moreover, collaborations between pharmaceutical companies and researchers are rapidly advancing next generation therapies, which will drive the market and adhere the strong demand for immunology treatment.
Immunology Market Restraints
High Expense of Immunology Therapies
-
The increasing costs of immunology therapies are an important factor restraining market growth. While these treatments are effective, they are also expensive, especially biologics and out of reach for a great deal of the global population. In developed countries, the cost of long-term therapy represents a huge burden on individual patients and health systems alike. This problem is further intensified by inadequate insurance and the associated out-of-pocket expenses, an issue particularly pronounced in the low and middle-income countries. Economic challenges result in inequitable access to care, impeding timely market penetration while demonstrating a critical need for lower-cost solutions.
Highly Complicated Regulatory Framework
-
In addition, the immunology market is limited by strict regulatory frameworks that create hurdles for the approval of new therapies. Regulatory agencies demand a lot of clinical trials to validate efficacy and safety of treatments making manufacturers invest a lot of time and financial resources. These regulatory barriers pose challenges, especially to small and medium-size firms. Addition to this, the complexity of global regulatory compliance poses a significant barrier to the expansion of the immunology market.
Request Free Customization of this report to help us to meet your business objectives.
Immunology Market Competitive Landscape
The immunology industry is highly competitive with the dominance of global giants and a high input of new entrants focusing on first-in-class therapies. The market is dominated by key players including AbbVie, Roche and Johnson & Johnson that have respective blockbuster biologics and broad R&D pipelines. Strategic alliances, mergers and acquisitions are becoming common, allowing firms to bolster their portfolios and geographic scope. Disruptive technologies from startups working in precision medicine and immunotherapy are gaining traction, creating challenges for the key players. Biosimilars are on the rise, impacting both the competitive landscape and forcing cost-effective solutions and market diversification. Although facing issues like patent losses and heavy regulation, innovation driven by competition leads to better treatments for patients and market expansion.
Top Player’s Company Profiles
- AbbVie, Inc. (U.S.)
- Janssen Global Services, LLC (U.S.)
- Eli Lilly and Company (U.S.)
- Novartis AG (Switzerland)
- Pfizer Inc. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Merck Sharp & Dohme Corp. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Amgen Inc. (U.S.)
- Astellas Pharma Inc. (Japan)
- UCB SA (Belgium)
- Sanofi (France)
- Gilead Sciences, Inc. (U.S.)
- Regeneron Pharmaceuticals, Inc. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Takeda Pharmaceutical Company Limited (Japan)
- Horizon Therapeutics plc (Ireland)
- Aimmune Therapeutics, Inc. (U.S.)
- Celgene Corporation (U.S.)
- Incyte Corporation (U.S.)
- Boehringer Ingelheim GmbH (Germany)
- Abbott Laboratories (U.S.)
Recent Developments
- In June 2023, Sandoz launched Hyrimoz injection, a hi-concentration formulation for the treatment of rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), and other immunological diseases.
- In November 2023, UCB reported long-term Phase 2b results for BIMZELX in ankylosing spondylitis The drug was effective in treating the features and manifestations of the disease and can give you five years of a good life.
- In October 2023, Novartis AG announced that the U.S. Food and Drug Administration (FDA) has approved Cosentyx. It is the first and only treatment approved for the hidradenitis suppurativa (HS) disease.
Immunology Key Market Trends
- Advent of Precision Medicine: The adoption of precision medicine is rapidly transforming the immunology market with personalized treatment approaches based on each unique genetic and molecular profiles. Not only does it have a great impact on therapeutic results but also reduces the side effects of the therapy, entailing the growing popularity of this approach among healthcare professionals and patients. Advancements in genomics, proteomics and biomarker research are leading to new targeted immunology therapies. Precision medicine is also in line with the trend towards more patient-centered care models.
- Emergence of Immuno-Oncology: There is a convergence of immunology with oncology, creating a game-changing immunology market trend. Immuno-oncology therapies, including immune checkpoint inhibitors and CAR-T cell therapies, are a new class of drugs that attempt to harness the immune system to fight cancer. The immuno-oncology segment is projected to grow rapidly, as collaboration between biopharma companies and academic institutions is one of the supporting factors. This trend also illustrates the expansion of immunology applications and the importance of its role in the evolution of cancer care.
Immunology Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the immunology industry is an ever-changing field being driven by ongoing advances in broader biotechnology in addition to the increasing incidence of autoimmune disease. This landscape has been largely defined by advances in the fields of monoclonal antibodies, biologics, and personalized medicine that have increased efficacy and enhanced patient outcomes. Some of the key drivers are increasing amount of spending on healthcare, favorable research funding initiatives from the government and stimulation need of targeted therapies. Some of the other key focus areas include chronic conditions like rheumatoid arthritis, psoriasis, and inflammatory bowel diseases. Moreover, the association of AI and big data with immunological research is augmenting drug discovery and clinical trials. The high development costs coupled with significant regulatory complexities pose challenges in ensuring the growth of this market however, the market persists due to its growing demand for therapies around the globe.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 95.8 billion |
| Market size value in 2031 | USD 269.96 billion |
| Growth Rate | 12.20% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Immunology Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Immunology Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Immunology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Immunology Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Immunology Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Immunology Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
